Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Phase 3 Clinical Trial Of Postmastectomy Hypofractionated Radiotherapy in High Risk Breast Cancer

NCT03319069 is registered in ClinicalTrials.gov with Ahmed Ahm as lead sponsor.

NCT NCT03319069
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03319069 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Phase 3 Clinical Trial Of Postmastectomy Hypofractionated Radiotherapy in High Risk Breast Cancer
Lead sponsor
Ahmed Ahm
Phase
Phase 3
Overall status
Unknown status
Start date
October 1, 2017
Completion date
September 1, 2019
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer